BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model

International Journal of Cancer

Volumn 101, Issue 3, 2002, Pages 270-279

  Grizzle, William E ^a   Mountz, John D ^b,c   Yang, Ping Ar ^b   Xu, Xin ^b   Sun, Sheher ^a   Van Zant, Gary E ^d   Williams, Robert W ^e   Hsu, Hui Chen ^b   Zhang, Huang Ge ^a,f  

^a University of Alabama at Birmingham   (United States)

^b The University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

Breast cancer; BXD mice; T cell; Tumor susceptibility

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC RECOMBINATION; HOST; IMMUNE RESPONSE; INBRED STRAIN; LYMPH NODE METASTASIS; LYMPHOCYTE DEPLETION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR NECROSIS;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; LYMPH NODES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED;

EID: 0037144361     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10606     Document Type: Article

References (51)

1. NK cells mediate the anti-tumor effects of El-deleted, type 5 adenovirus in a human tumor xenograft model
2. Human tumor models in the severe combined immune deficient (SCID) mouse
3. Experimental chemotherapy of murine melanomas: Is there a discrepancy compared to clinical experience?
4. Dendritic cells pulsed with apoptotic squamous cell carcinoma have anti-tumor effects when combined with interleukin-2
5. Loss of heterozygosity on murine chromosome 6 in 2-stage carcinogenesis: Evidence for a conserved tumor suppressor gene
6. Further characterization and high-resolution mapping of quantitative trait loci for ethanol-induced locomotor activity
7. + T cells during murine gamma-herpesvirus-induced infectious mononucleosis
8. Genomewide search for epistasis in a complex trait: Pentobarbital withdrawal convulsions in mice
9. Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth
10. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alphagalactosylceramide in mice
11. Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines
12. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction
13. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily
14. Gene mapping of SEZ group genes and determination of pentylenetetrazol susceptible quantitative trait loci in the mouse chromosome
15. Human and mouse chromosomal mapping of Stac, a neuron-specific protein with an SH3 domain
16. Complex trait analysis of the hippocampus: Mapping and biometric analysis of 2 novel gene loci with specific effects on hippocampal structure in mice
17. Natural variation in neuron number in mice is linked to a major quantitative trait locus on chr 11
18. Allelic variation in the GABAA receptor gamma2 subunit is associated with genetic susceptibility to ethanol-induced motor incoordination and hypothermia, conditioned taste aversion, and withdrawal in BXD/Ty recombinant inbred mice
19. Genetic and immunological parameters governing in vivo susceptibility/resistance to retrovirally induced murine malignant histiocytosis
20. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells
21. Characterization and mapping of the gene encoding mouse proteasome subunit DELTA (Lmpl9)
22. Antigen recognition by a T cell clone outside the context of the major histocompatibility complex. A role for Mls in antigen presentation
23. Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes
24. Genetic analysis of experimentally induced lupus in mice
25. TS/A: A new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma
26. Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system
27. Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice
28. Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice
29. High incidence of point mutations of p53 suppressor oncogene in patients with myelodysplastic syndrome among atomic-bomb survivors: A 10-year follow-up
30. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck
31. A role for p53 in the frequency and mechanism of mutation
32. Increased p53 mutation frequency during tumor progression-results from a breast cancer cohort
33. Identification of hepatocarcinogen-resistance genes in DBA/2 mice
34. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice
35. Genetic dissection of age-related changes of immune function in mice
36. CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen
37. Cancer-induced defective cytotoxic T lymphocyte effector function: Another mechanism how antigenic tumors escape immune-mediated killing
38. A novel human xenograft model of inflammatory breast cancer
39. Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
40. Growth of human tumor xenografts in nude mice and mice with severe combined immunodeficiency (SCID)
41. Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: Enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene
42. Metastasis from human breast cancer cell lines
43. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients
44. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor
45. Arginine modulated cyclosporine-induced immune suppression in rats transplanted with gastric cancer cells
46. Melanoma cell expression of Fas(Apo-1/CD95) ligand; implications for tumor immune escape
47. Immune privilege and FasL: Two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells
48. Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model
49. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: A role for inflammatory cells in tumor invasion and angiogenesis
50. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgam maRI (CD64) and fcalphaRI (CD89)
51. Human neutrophils facilitate tumor cell transendothelial migration